冠科美博股价异动，财报显示营收为零

Group 1 - The core focus of the company is on the development of oncology therapies [1] - As of December 19, 2025, the company's stock price experienced a notable increase of 5.52% in a single day [1] - Financial reports indicate that the company has generated zero revenue and has a negative net profit [1]